• 1
    Dorainswamy PM. Non-choloinergic strategies for treating and preventing AD. CNS Drugs 2002; 12: 811824.
  • 2
    Prasad N, Cole WC, Prasad K. Risk factors for AD: role of multiple antioxidants, non-steroidal anti-inflammatory and cholinergic agents alone or in combination in prevention and treatment. J Am Coll Nutr 2002; 21: 506522.
  • 3
    Kramer AF, Hahn S, Cohen NJ et al. Aging, fitness and neurocognitive function. Nature 1999; 400: 418419.
  • 4
    Verghese J, Lipton RB, Katz MJ et al. Leisure activities and the risk of dementia in the elderly. N Engl J Med 2003; 348: 25082518.
  • 5
    Larson EB, Wang L, Bowen JD et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 2006; 144: 7381.
  • 6
    Scarmeas N, Stern Y, Tang MX et al. Mediterranean diet and risk for Alzheimer’s disease. Ann Neurol 2006; 59: 912921.
  • 7
    Lazarov O, Robinson J, Tang YP et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 2005; 120: 701713.
  • 8
    Lim GP, Calon F, Morihara T et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 2005; 23: 30323040.
  • 9
    Petersen RC, Thomas RG, Grundman M et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 2005; 352: 23792388.
  • 10
    Wang J, Ho L, Qin W et al. Caloric restriction attenuates beta-amyloid neuropathology in a mouse model of Alzheimer’s disease. FASEB J 2005; 19: 659661.
  • 11
    Hendrie HC, Ogunniyi A, Hall KS et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA 2001; 285: 739747.
  • 12
    Yamada T, Kadekaru H, Matsumoto S et al. Prevalence of dementia in older Japanese–Brazilian population. Psychiatry Clin Neurosci 2002; 48: 163172.
  • 13
    Grant WB. Dietary links to Alzheimer’s disease. Alz Dis Rev 1987; 2: 4255.
  • 14
    Engelhart MJ, Geerling MI, Ruitenberg A et al. Dietary intake of antioxidants and risk of dementia: does fat matter? The Rotterdam Study. Neurology 2002; 59: 19151921.
  • 15
    Young G, Conquer J. Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev 2005; 45: 128.
  • 16
    Salem N Jr, Wegher B, Mena P et al. Arachidonic acid and docosahexaenoic acid are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci USA 1996; 93: 4954.
  • 17
    Conquer JA, Holub BJ. Dietary docosahexaenoic acid as a source of eicosapentanoic acid in vegetarians and omnivores. Lipids 1997; 32: 341345.
  • 18
    Simopolous AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54: 438463.
  • 19
    Kris-Etherton PM, Shaffer D, Yu-Poth S et al. Polysaturated fatty acids in the food chain in the United State. Am J Clin Nutr 2000; 71: S179S188.
  • 20
    Sugano M, Hirahara F. Polyunsaturared fatty acids in the food chain in Japan. Am J Clin Nutr 2000; 71: S189S196.
  • 21
    Heude B, Ducimetiere P, Berr C. Cognitive decline and fatty acid consumption of erythrocyte membrane. The EVA Study. Am J Clin Nutr 2003; 77: 803808.
  • 22
    Barberger-Gateau P, Letenneur L, Deschamps V et al. Fish, meat, and risk of dementia: cohort study. Br Med J 2002; 325: 932933.
  • 23
    Morris MC, Evans DA, Bienias JL et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003; 60: 940946.
  • 24
    Kalmijn S, Van Boxtel MPJ, Ocke M et al. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004; 62: 275280.
  • 25
    Luchsinger JA, Tang MX, Stern Y et al. Diabetes mellitus and risk of Alzheimer’s disease and dementia with stroke in multiethnic cohort. Am J Epidemiol 2001; 154: 635641.
  • 26
    Boyt AA, Taddei TK, Hallmeyer J et al. The effect of insulin and glucose on the plasma concentration of Alzheimer’s amyloid precursor protein. Neuroscience 2000; 95: 727734.
  • 27
    Edbauer D, Willem M, Lammich S et al. Insulin degrading enzyme rapidly removes the βamyloid precursor protein intracellular domain (AICD). J Biol Chem 2002; 277: 1338913393.
  • 28
    Gasparini L, Gouras GK, Wang R et al. Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 2001; 21: 25612570.
  • 29
    Manco M, Calvani C, Mingrone G. Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab 2004; 6: 402413.
  • 30
    Holness MJ, Greenwood GK, Smith ND et al. Diabetogenic impact of long-chain omega-3 fatty acids on pancreatic beta-cell function and regulation of endogenous glucose production. Endocrinology 2003; 144: 39583968.
  • 31
    Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and risk for dementia and related pathologies: the Honolulu Asia Aging Study. Diabetes 2002; 51: 12561262.
  • 32
    Frank B, Gupts S. A review of antioxidants and Alzheimer’s disease. Ann Clin Psychiatry 2005; 17: 269286.
  • 33
    Gracy RW, Talent JM, Kong Y et al. Reactive oxygen species: the unavoidable environmental insult? Mutat Res 1999; 428: 1722.
  • 34
    Melo JB, Agostinho P, Oliveira CR. Involvement of oxidative stress in the enhancement of acetylcholinesterase activity induced by amyloid beta-peptide. Neurosci Res 2003; 45: 117127.
  • 35
    Engelhart MJ, Geerlings MI, Ruitenberg A et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287: 32233229.
  • 36
    Luchsinger JA, Tang MX, Shea S et al. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003; 60: 203208.
  • 37
    Laurin D, Masaki KH, Foley DJ et al. Midlife dietary intake of antioxidants and risk of late-life incident dementia. The Honolulu-Asia Aging Study. Am J Epidemiol 2004; 159: 959967.
  • 38
    Mecocci P. Oxidative stress in mild cognitive impairment and AD: a continuum. J Alzheimers Dis 2003; 24: 915919.
  • 39
    Morris MC, Beckett LA, Scerr PA et al. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord 1998; 12: 121126.
  • 40
    Zandi PP, Anthony JC, Khachaturian AS et al. Cache county Study Group. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements. The Cache County Study. Arch Neurol 2004; 61: 8288.
  • 41
    Group HPSC. The MRC/BHF heart protection study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomized placebo controlled trial. Lancet 2002; 360: 2333.
  • 42
    Luchsinger JA, Mayeux R. Dietary factors and Alzheimer’s disease. Lancet Neurol 2004; 3: 579587.
  • 43
    Luo Y, Smith JV, Paramasivam V et al. Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci USA 2002; 99: 1219712202.
  • 44
    DeFeudis FV, Drieu K. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr Drug Targets 2000; 1: 2558.
  • 45
    Solomon PR, Adams F, Silver A et al. Ginkgo for memory enhancement: a randomized controlled trial. JAMA 2002; 288: 835840.
  • 46
    Hoerr R. Treatment effects of EGb 761 and cholinesterase inhibitors. Why available studies do not demonstrate superiority of the latter. Phytomedicine 2005; 12: 598600.